We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Jul 2019 11:34

RNS Number : 7376G
Cathay International Holdings Ld
25 July 2019
 

 25 July 2019

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

Cathay International Holdings Limited

("Cathay", the "Company" or the "Group")

Trading update

Hong Kong, 25 July 2019 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China (the "PRC"), provides a trading update for the six months ended 30 June 2019.

The Company expects a lower Group sales and profits in the first half 2019 than the same period last year.

As Lansen announced today in Hong Kong, Lansen expects to have noticeable decrease in its net profits for H1 2019 as compared with the net profit for H1 2018 due to the following reasons:

1. As stated in our 2018 annual report, Lansen has implemented a number of new strategic initiatives in its pharmaceutical business, in response to the challenging regulatory environment in China, by developing its own products such as Pafulin, Sicorten Plus, and certain featured pharmaceuticals; and reducing reliance on agency products. As a result, in the first half of the current financial year, Lansen's sales are below the same period last year.

2. A number of provisions and write-offs have been made against old and slow moving inventory.

3. As at 21 June 2019, Lansen decided not to exercise the put option (the "Put Option") to require Natural Dailyhealth to buy back its holding of 30% equity interest in Natural Dailyhealth. As a result, it has written off the related put option value.

Despite the short term impact on Lansen's results from the new strategic initiatives, Lansen sees improvement in its pharmaceutical segment and expects this segment's profit to be higher than that in same period last year, and looks forward to continuing improvement in the second half.

At Haizi, trading has been adversely impacted by a decrease in the market price for inositol and its results are expected to be below 2018.

Natural Dailyhealth and Botai are both trading broadly in line with expectations.

Our hotel remains profitable, although occupancy and average room rates are below last year and profits will be lower for the first half.

 

The Company's results for six months ended 30 June 2019 will be released in late August.

 

 

For further enquiries, please contact:

 

Cathay International Holdings Limited

Eric Siu (Finance Director)

Patrick Sung (Director and Controller)

 

 

Tel: +852 2828 9289

Consilium Strategic Communications

Mary-Jane Elliott / Matthew Neal / Lindsey Neville

 

 

Tel: +44 (0) 203 709 5702

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKPDNKBKDDOB
Date   Source Headline
29th Jan 20187:18 amRNSLansen Change of Director
27th Dec 201712:39 pmRNSUpdate on Settlement of A Litigation
22nd Sep 201711:05 amRNSResults of Special General Meeting
19th Sep 201710:15 amRNSLansen's second share reduction plan of Starry
1st Sep 20173:11 pmRNSUpdate on Litigation against Lansen's subsidiary
30th Aug 20179:48 amRNSInterim Results for Six Months Ended 30 June 2017
30th Aug 20179:45 amRNSNotice of Special General Meeting
16th Aug 20177:00 amRNSNotice of Results
21st Jun 201711:55 amRNSResult of AGM
20th Jun 20177:00 amRNSSettlement of insurance claims received by Lansen
19th Jun 201711:54 amRNSLansen's declaration & payment of special dividend
7th Jun 201710:14 amRNSLansen's proposal to approve a special dividend
28th Apr 20177:00 amRNSAnnual Report and Accounts
7th Apr 201711:37 amRNSHoldings in Company
31st Mar 20179:50 amRNSLansen subsidiary enters distribution agreement
30th Mar 20179:20 amRNSAnnual Results for the Year Ended 31 December 2016
16th Mar 20177:00 amRNSNotice of Annual Results 2016
15th Mar 201711:57 amRNSNotification of class 2 transaction
9th Mar 20179:05 amRNSLansen's share reduction plan of Starry
20th Sep 201610:44 amRNSEntrusted Manufacturing Framework Agreement
31st Aug 20169:48 amRNSHalf-year Report
17th Aug 20167:00 amRNSNotice of Interim Results 2016
13th Jul 201611:02 amRNSResult of Lansen EGM
24th Jun 20161:15 pmRNSLansen Shares Subscription and Agreement
20th Jun 201611:17 amRNSResult of AGM
5th May 20161:00 pmRNSNotification of Transactions
5th May 20161:00 pmRNSNotification of Transactions
5th May 20161:00 pmRNSClarification Announcement - transaction in Shares
22nd Apr 20168:10 amRNSAnnual Report and Accounts
5th Apr 201610:11 amRNSDirector Appointment
30th Mar 201610:01 amRNSAnnual Results for the Year Ended 31 December 2015
24th Mar 20169:21 amRNSNotification of class 2 transaction
16th Mar 201610:01 amRNSNotice of Annual Results 2015
9th Mar 201610:04 amRNSStarry IPO
7th Mar 201610:34 amRNSLansen's release of its Trading Update
17th Feb 20168:50 amRNSLansen's Starry, obtains listing approval
29th Dec 20158:45 amRNSTrading Update
1st Dec 20155:51 pmRNSHolding(s) in Company
28th Aug 201510:12 amRNSHalf Yearly Report
17th Aug 20157:00 amRNSNotice of Interim Results
6th Jul 201510:25 amRNSLitigation against Lansen's sub in Ningbo, the PRC
15th Jun 20151:18 pmRNSLansen enters a distribution agreement with Botai
11th Jun 20159:38 amRNSDistribution agreement with Bio-Rad China
5th Jun 20157:01 amRNSAppointment of New Chairman
5th Jun 20157:00 amRNSResult of AGM
11th May 20157:00 amRNSAppointment of Broker
17th Apr 20159:03 amRNSTransaction in Own Shares
16th Apr 20153:44 pmRNSAnnual Report and Accounts
15th Apr 20158:59 amRNSTransaction in Own Shares
9th Apr 20157:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.